ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7Zhen Lü, Robert C. Bast|Cell Death and Differentiation|2014Cited by 78
ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenograftsMichele N. Washington, Zhen Lü|Cell Death and Disease|2015Cited by 62
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cellsMara Artibani, Ahmed A. Ahmed, Nina Wietek et al.|JCI Insight|2021Cited by 42
Preparation and <i>in vitro</i> and <i>in vivo</i> evaluation of quercetin-loaded mixed micelles for oral deliveryZhen Lü, Guangxi Zhai, CuiPing Bu et al.|Bioscience Biotechnology and Biochemistry|2018Cited by 32
DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomasGamze Bildik, Zhen Lü|Autophagy|2024Cited by 13